Court Revived Antitrust Claims Against Align Technology

The Ninth Circuit reversed a summary judgment regarding Align's alleged use of patent litigation to stifle competition.

Updated on Oct. 5, 2026 in Healthcare

Bold flat-color editorial illustration of a single architectural pillar, symbolizing legal authority and structural weight.
The Ninth Circuit Court of Appeals has reinstated an antitrust lawsuit against Align Technology, reversing a prior judgment concerning the company's patent litigation strategy. AI Illustration. Upload story photo >

Live Poll

Should companies be allowed to limit third-party interoperability to protect their own market share?

The Court of Appeals for the Ninth Circuit has revived an antitrust lawsuit against Align Technology, reversing a previous summary judgment in the company's favor. The court found that a reasonable factfinder could conclude the firm used patent litigation to terminate interoperability with competing systems.

Why it matters

The ruling centers on allegations that the company used legal strategy to block competitors from utilizing open systems, thereby protecting its clear aligner product from rival market pressure.

The ruling concerns the company's clear aligner business and its digital intraoral scanners. The core investigation remains unresolved as the case moves forward to evaluate whether the firm intentionally thwarted market competition.

The players

Align Technology

This is a global medical device company best known for manufacturing the Invisalign clear aligner system.

3Shape

This company develops 3D scanners and software solutions for the dental and audio industries.

Ninth Circuit Court of Appeals

This is the federal appellate court responsible for cases arising from the nine Western states and two territories of the United States.

The details

Align Technology allegedly terminated interoperability with 3Shape's open system to prevent other clear aligner products from competing directly with its Invisalign brand. The appellate court determined there was sufficient evidence for a factfinder to consider if the company used patent litigation as a pretext to undermine industry rivals.

Timeline

  1. The Ninth Circuit Court of Appeals issued the opinion reviving the antitrust case on October 5, 2026.

Market Landscape

This case highlights the increasing scrutiny of how dominant firms use patent litigation to maintain control over proprietary digital ecosystems. It positions the company against competitors that rely on open-system interoperability to gain traction in the dental technology sector.

The potential changes in interoperability could eventually impact dental providers who use digital scanners and aligner systems. Consumers might see shifts in the competitive landscape as the court process determines whether rival companies can access the necessary technology to lower prices.

The takeaway

Legal challenges regarding interoperability highlight how proprietary technology can restrict broader market competition. Understanding these corporate disputes provides insight into the potential for future innovation and pricing flexibility within the specialized dental care sector.

Further reading

For more context on ongoing legal challenges within the medical industry, visit the United States Healthcare section.

Live Poll

Should companies be allowed to limit third-party interoperability to protect their own market share?